Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]
Tandem Diabetes Care
Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
Tandem Diabetes Care (Nasdaq:TNDM) today announced the introduction of a new automated insulin delivery algorithm. Our sister site, Drug Delivery Business News, reports that the San Diego-based company launched the next-generation Control-IQ+ technology in the U.S. today. San Diego-based Tandem won FDA clearance for the next-generation algorithm at the end of last month. It joined Insulet in […]
FDA clears Tandem Diabetes Care’s next-gen automated insulin delivery algorithm for type 2 diabetes
Tandem Diabetes Care (Nasdaq:TNDM) today announced a major regulatory win that brings its diabetes technology to more patients. Our sister site, Drug Delivery Business News, reports today that the FDA cleared Tandem’s Control-IQ+ automated insulin delivery algorithm for people with type 2 diabetes. Control IQ+ builds on the company’s proven Control-IQ algorithm. It also includes […]
The top medtech stories of 2024
AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech stories. Meanwhile, medical device companies have been seeking more tuck-in M&A — and continuing to refocus and boost operational efficiency — to better prepare for whatever the future brings. Here are the top medtech stories that caught the attention […]
Tandem stock rises on 31% Q3 sales growth, raised guidance
Tandem Diabetes Care (Nasdaq:TNDM) stock is on the rise following strong third-quarter financial results from the insulin pump maker. Our sister site, Drug Delivery Business News, reports today that the company topped Wall Street forecasts and raised its full-year guidance following another quarter of growth. As a result, shares of TNDM rose 5% to $35.85 […]
The 9 largest diabetes tech companies in the world
Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]
Tandem Diabetes Care integrates t:slim X2 with Dexcom CGMs in Canada
Tandem Diabetes Care (Nasdaq:TNDM) continues to expand its diabetes treatment partnership with Dexcom (Nasdaq:DXCM). Our sibling site, Drug Delivery Business News, reported today that Tandem has launched its updated t:slim X2 insulin pump software with Dexcom CGMs in Canada. San Diego–based Tandem now offers the t:slim X2 pump software with the Dexcom G6 and G7 continuous glucose […]
The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions
The American Diabetes Association took to Orlando, Florida, the past few days for its 84th Scientific Sessions as optimism grows over diabetes tech. Topics covered included expanding technologies to the type 2 diabetes population (90% of people with diabetes), GLP-1 drugs, automation, broadening user bases and more. The usual big-hitters stepped up to the plate […]
Tandem Diabetes Care reports improved quality of life with Mobi automated insulin delivery system
Tandem Diabetes Care (Nasdaq:TNDM) today announced real-world insights highlighting user satisfaction with its Mobi automated insulin pump. San Diego-based Tandem launched Mobi, the world’s smallest, durable automated insulin delivery (AID) system in the U.S. this year. It received FDA clearance for people with diabetes ages six and up in July 2023. The system pairs with both the […]
Tandem Diabetes Care has a new COO
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed Jean-Claude “JC” Kyrillos as its new EVP and COO. Kyrillos’ appointment goes into effect on June 21, 2024. He joins Tandem with more than 20 years of experience in global executive leadership across medtech, digital health and healthcare management. Most recently, Kyrillos served in operating company […]
Tandem pairs Mobi automated insulin pump with Dexcom G7
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it integrated its Mobi insulin pump with the Dexcom G7 continuous glucose monitor (CGM). Already compatible with the previous-generation G6, Mobi now pairs with Dexcom’s latest-generation CGM. San Diego-based Tandem launched Mobi, the world’s smallest, durable automated insulin delivery (AID) system in the U.S. this year. It received […]
